http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
김부성,김석윤,Kim, Boo-Sung,Kim, Seok-Yoon 대한전자공학회 1999 電子工學會論文誌, C Vol.c36 No.8
빠르고 정확한 결과를 얻기 위해서 타이밍 수준에서의 회로 해석이 이루어지며, 게이트와 연결선에서의 신호 지연 해석은 회로의 설계 검증을 위하여 필수적이다. 본 논문에서는 CMOS 회로 게이트에서의 지연 시간과 연결선의 지연 해석을 위한 초기 천이 시간을 동시에 계산할 수 있는 방법을 제시한다. 회로 연결선의 유효 커패시턴스 개념을 이용하여 게이트의 지연 시간과 게이트에서의 구동 저항을 고려한 연결선 선형 전압원의 천이 시간을 계산한다. 게이트 지연과 연결선 선형 전압원의 천이 시간을 구하는 과정은 예비 특성화된 게이트 타이밍 데이터를 이용하여 반복적인 연산과정을 통하여 동시에 구하게 된다. 기존의 게이트 지연 계산 알고리즘은 연결선 선형 전압원의 천이 시간을 위해 별도의 게이트 특성 데이터를 필요로 하였으나, 본 논문에서 제시하는 방법은 계산 과정 중에 생성된 데이터를 이용함으로써 현재의 예비 특성화 방법을 수정하지 않고서도 효율적인 타이밍 수준의 게이트 및 연결선 지연 시간 예측이 가능하도록 하였다. Timing-level circuit analyses are used to obtain fast and accurate results, and the analysis of gate and interconnect delay is necessary to validate the correctness of circuit design. This paper proposes an efficient algorithm which simultaneously calculates the gate delay and the transition time of linearized voltage source for subsequent interconnect delay calculation. The notion of effective capacitance is used to calculate the gate delay and the transition time of linearized voltage source which considers the on-resistance of driving gate. The procedure for obtaining the gate delay and the transition time of linearized voltage source has been developed through an iterative operation using the precharacterized data of gates. While previous methods require extra information for the transition time calculation of linearized voltage sources, our method uses the derived data during the gate delay calculation process, which does not require any change in the precharacterization process.
김부성(Boo Sung Kim),박석영(Suk Young Park),임계순(Kae Soon Im),김영우(Young Woo Kim),백남종(Nam Jong Baeg),박준철(Jun Chul Park),신호균(Ho Kyun shin),김석영(Suk Yong Kim) 대한소화기학회 1987 대한소화기학회지 Vol.19 No.2
Adenomatous polyps of the stomach have a well-defined risk for malignancy. As lesions become increasingly seesile and of increasing size, the risk of cancer increases. Recently most peduncleated or small sessile polyps can be removed with an electrocautery snare during gastroscopy. But endos- copic removal of larger sessile polyps or those with abroad pedicle may cause severe bleeding, so such lesions should be removed surgically. We experienced a flat carpet type adenomatous polyp of the stomach. A'e did endoscopic Nd-YAG laser therapy without complications.
간장 ( 肝臟 ) 및 담도 ( 膽道 ) : 항결핵약제 투여로 인한 간독작용에 대한 임상적 고찰
김부성(Boo Sung Kim),이창돈(Chang Don Lee),박영민(Young Min Park),한남익(Nam Ik Han),김인식(In Sik Kim),최재경(Jae Kyung Choi),이숙영(Sook Young Lee),조현미(Hyun Mee Cho) 대한소화기학회 1991 대한소화기학회지 Vol.23 No.1
N/A From January 1981-December 1989, thirty-four patients in whom there was clinical or biochemical evidence of liver damage during combination antituberculous therapy of isoniazid and rifampin with or without pyrazinamide were studied. The results were as follows; 1) Fifteen patients (44%) were entirely asymptomatic at the time of detecting hepatotoxicity. 2) Nineteen patients (56%) were the maximum serum bilirubin levels that below 1. 0 mg per 100 ml. 3) The mean time presenting clinical hepatotoxicity during antituberculous therapy was 34 days, 19 patients (56%) were below 2 weeks and 26 patients (76%) were below 4 weeks. 4) The mean time normalizing liver function after hepatotoxic drugs withdrawal is 15 days, and 30 patients (88%) were below 4 weeks. 5) Readministrations of isoniazid, rifampin and pyrazinamide were successful in 72 %, 83 % and 85% of the patients. Conclusively, biochemical monitoring should be done routinely in patients receiving antituberculous therapy to avoid the development of toxic hepatic reactions. However, in most cases, it is possible to readminister the antituberculous agents from small dosages without toxic hepatic reactions.
한국인 소화성 궤양환자에 대한 Proglumide 의 치료효과에 관한 임상적 관찰
김부성(Boo Sung Kim),유재영(Jae Young Yoo) 대한소화기학회 1981 대한소화기학회지 Vol.13 No.2
N/A Proglumiie(ilid) was given to 14 gastric and, 5 duodenel ulcer. Out-patients, at a dose of 1600 mg daily in 4 divided doses, for a period of 4 to 12 weeks. The course of ulcers was assessed by serial endoscopy. Complete healing was observed in 12 patients, and signifincant size reduction in further 3, totalling 79% effective results(79% in gastric and 80% in duodenal ulcer) The administration of proglumide was associated with decreased severity and frequetncy of symptoms(pain, heartborn, bloating and belching). All patienis tolerated perfectly the drug. In particular, none of the side-effects usually associated with anti-cholinergic (anti-muscarinic) ar H2-blocking treatments were observed. Proglumide therefore exerted a significant healing action, without unw anted side-reactions.
김부성(Boo Sung Kim),이창돈(Chang Don Lee),정진우(Jin Woo Jeong),최상욱(Sang wook Choi),박영민(Young Min Park),한남익(Nam Ik Han),유석환(Suk Hwan Yu) 대한소화기학회 1989 대한소화기학회지 Vol.21 No.1
N/A Nizatidine is new H2-receptor blocker with a thiazole ring. We evaluate the clinical efficacy and safety of the Nizatidine in 30 cases of endoscopically-proven peptic ulcer diseases. Nizatidine was administered 150 mg twice daily for 4 or 8 weeks and then followed by endoscopy. Overall improvement of peptic ulcer diseases by endoscopic evaluation noted in 26 (86.9%) of 30 patients. 7 out of 8 cases (87.5%) of gastric ulcers and 19 out of 22 cases (86.3%) of duodenal ulcers had been healed in 4 or 8 weeks. Clinical symptoms of peptic ulcer diseases had been improved in 29 out of 30 cases (96.7%) after 4 or 8 weeks medication with Nizatidine. No significant clinical side effects and laboratory changes had been noticed during therapy. In conclusion, nizatidine was effective and safe drug for the treatment of peptic ulcer diseases.